PC
Philip Chacko Mundanilkunnathil
About Philip Chacko Mundanilkunnathil
Data last updated:
Philip Chacko Mundanilkunnathil is a Nominee Director at Sterling Biotech Limited (since 2025). The companies operate in Pharma, Chemicals and Materials and Real Estate and Construction. Sterling Biotech Limited reported revenue of ₹767 Cr (FY 2025). Earlier, Philip Chacko Mundanilkunnathil was a Director at Capexil (2022–2023) and Director at Bamni Proteins Limited (2022–2023) and 20 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 27 Jan 2025 | 1985 | ₹767 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Dec 2022 | 1958 | ₹14.84 Cr (FY 2024) | Active | |
| Director | 04 Feb 2022 | 1997 | ₹12.02 Cr (FY 2025) | Active | |
| Managing Director | 01 Apr 2022 | 1975 | ₹545 Cr (FY 2025) | Active | |
| Director | 01 Feb 2007 | 2007 | Active | ||
| Director | 01 Feb 2007 | 2007 | ₹15.30 Cr (FY 2016) | Active | |
| Director | 31 Jan 2007 | 2007 | Strike Off | ||
| Director | 06 Feb 2007 | 2007 | Strike Off | ||
| Director | 31 Jan 2007 | 2007 | Active | ||
| Additional Director | 06 May 2008 | 2007 | Strike Off | ||
| Designated Partner | 12 Dec 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Philip Chacko Mundanilkunnathil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aftab Mathur | 06594968 | Sterling Biotech Limited | Nominee Director |
| Alok Kumar Garg | 10630493 | Sterling Biotech Limited | Nominee Director |
| Anil Shantilal Inani | Sterling Biotech Limited | Cfo | |
| Keyur Anilkumar Parekh | 08868570 | Sterling Biotech Limited | Nominee Director |
| Monisha Prabhu Macedo | 00144660 | Sterling Biotech Limited | Nominee Director |
| Neha Champaben Prajapati | Sterling Biotech Limited | Company Secretary | |
| Priyadarshan Kumar Singh | 11606849 | Sterling Biotech Limited | Additional Director |
| Vishal Jyotindra Gor | 08787850 | Sterling Biotech Limited | Nominee Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Philip Chacko Mundanilkunnathil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Philip Chacko Mundanilkunnathil
Philip Chacko Mundanilkunnathil currently holds 1 directorship: Sterling Biotech Limited (Nominee Director, since 27 Jan 2025, revenue ₹767 Cr (FY 2025)).
Philip Chacko Mundanilkunnathil was first appointed on 31 Jan 2007 as Director at Vijetha Real Estate Developers Private Limited. The most recent appointment on record is 27 Jan 2025 at Sterling Biotech Limited.
Philip Chacko Mundanilkunnathil held 22 earlier board appointments: Capexil (Director, 20 Dec 2022 to 31 May 2023); Bamni Proteins Limited (Director, 04 Feb 2022 to 31 May 2023); Nitta Gelatin India Limited (Managing Director, 01 Apr 2022 to 31 May 2023); Pragmatic Real Estates Developers Private Limited (Director, 01 Feb 2007 to 19 May 2008); Dakshin Realties Private Limited (Director, 01 Feb 2007 to 19 May 2008); and 17 more.
The current boards of Philip Chacko Mundanilkunnathil's companies include Aftab Mathur (Sterling Biotech Limited), Alok Kumar Garg (Sterling Biotech Limited), Anil Shantilal Inani (Sterling Biotech Limited), Keyur Anilkumar Parekh (Sterling Biotech Limited), Monisha Prabhu Macedo (Sterling Biotech Limited), Neha Champaben Prajapati (Sterling Biotech Limited), among others.